El GLP-1 abreviatura, en ingls, de pptido similar al glucagn tipo 1 es una hormona natural que el cuerpo produce cuando ingerimos alimentos
105 , e3961e3970 (2020)
Proponents suggest that lower doses may confer benefits whilst minimising adverse effects, though this approach remains experimental and is not supported by current regulatory approvals
Phase 2 results suggested lower nausea and gastrointestinal side effects than has been reported in injectable GLP-1 trials, with more reports of fatigue
Several approaches have been described, including the use of natural albumin-binding proteins such as antibody fragments binding to serum albumin 22,23,24 , albumin-binding peptides 25 , the streptococcal protein G-derived albumin-binding domain 26,27 , and serum albumin-binding DARPin 28
After up to a year, the GLP-1 group showed significantly lower disease activity, less pain, improved cholesterol and HbA1c, and meaningful weight loss, with inflammatory markers (CRP and ESR) also improving
